Arsenio Nueda

1.3k total citations · 1 hit paper
29 papers, 959 citations indexed

About

Arsenio Nueda is a scholar working on Molecular Biology, Immunology and Allergy and Immunology. According to data from OpenAlex, Arsenio Nueda has authored 29 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Immunology and Allergy and 11 papers in Immunology. Recurrent topics in Arsenio Nueda's work include Cell Adhesion Molecules Research (9 papers), Immune Response and Inflammation (6 papers) and Adenosine and Purinergic Signaling (5 papers). Arsenio Nueda is often cited by papers focused on Cell Adhesion Molecules Research (9 papers), Immune Response and Inflammation (6 papers) and Adenosine and Purinergic Signaling (5 papers). Arsenio Nueda collaborates with scholars based in Spain, United States and France. Arsenio Nueda's co-authors include William S. Dynan, Ángel L. Corbí, Odile Filhol, Véronique Martel, Claude Cochet, Fabien Vincent, Mark Mercola, Monica Schenone, Marco Prunotto and Jonathan Lee and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Arsenio Nueda

28 papers receiving 940 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phenotypic drug discovery: recent successes, lessons learned and new directions

2022 165 citations Fabien Vincent, Arsenio Nueda et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Arsenio Nueda

Since Specialization

Citations

This map shows the geographic impact of Arsenio Nueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arsenio Nueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arsenio Nueda more than expected).

Fields of papers citing papers by Arsenio Nueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arsenio Nueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arsenio Nueda. The network helps show where Arsenio Nueda may publish in the future.

Co-authorship network of co-authors of Arsenio Nueda

This figure shows the co-authorship network connecting the top 25 collaborators of Arsenio Nueda. A scholar is included among the top collaborators of Arsenio Nueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arsenio Nueda. Arsenio Nueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterisation and Profiling of Standard Atopic Dermatitis Therapies in a Chronic Dermatitis Murine Model Induced by Oxazolone 2024 ·Experimental Dermatology ·Elena Calama, (unknown), Juan L. Trincado, Arsenio Nueda, Fèlix Gil, (unknown), Núria Godessart, Amadeu Gavaldà	0
2	Phenotypic drug discovery: recent successes, lessons learned and new directions breakdown → 2022 ·Nature Reviews Drug Discovery ·Fabien Vincent, Arsenio Nueda, Jonathan Lee, Monica Schenone, Marco Prunotto, Mark Mercola	165
3	Publisher Correction: Phenotypic drug discovery: recent successes, lessons learned and new directions 2022 ·Nature Reviews Drug Discovery ·Fabien Vincent, Arsenio Nueda, (unknown), Monica Schenone, Marco Prunotto, Mark Mercola	6
4	Application of a phenotypic drug discovery strategy to identify biological and chemical starting points for inhibition of TSLP production in lung epithelial cells 2018 ·PLoS ONE ·Adelina Orellana, Vicente García‐González, Rosa López-Gigosos, (unknown), (unknown), Julia E. Sepúlveda-Díaz, (unknown), (unknown), (unknown), (unknown), Vı́ctor Segarra, Dolors Vilella, Rajneesh Malhotra, Paul Eastwood, Anna Planagumà, Montserrat Miralpeix, Arsenio Nueda	8
5	Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation 2015 ·Pulmonary Pharmacology & Therapeutics ·Anna Planagumà, Teresa Domènech, (unknown), Elena Calama, Vicente García‐González, Rosa López-Gigosos, Mariona Aulí, Manuel López, Sı́lvia Fonquerna, Israel Ramos, J. De Alba, Arsenio Nueda, Neus Prats, Vı́ctor Segarra, Montserrat Miralpeix, Manfred Lehner	37
6	Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A2B adenosine receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Paul Eastwood, (unknown), Sergio Paredes, Arsenio Nueda, Teresa Domènech, Joan Albertí, Bernat Vidal	16
7	Discovery of potent and selective bicyclic A2B adenosine receptor antagonists via bioisosteric amide replacement 2010 ·Bioorganic & Medicinal Chemistry Letters ·Paul Eastwood, (unknown), Sergio Paredes, Sı́lvia Fonquerna, (unknown), (unknown), Arsenio Nueda, Teresa Domènech, Raquel F. Reinoso, Bernat Vidal	15
8	CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example 2007 ·European Journal of Medicinal Chemistry ·Ana Castro, (unknown), Carmen Gil, Félix Calderón, Teresa Domènech, Arsenio Nueda, Ana Martı́nez	29
9	New pyrrolopyrimidin-6-yl benzenesulfonamides: Potent A2B adenosine receptor antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Arsenio Nueda, José Luis Dı́az, Jörge Beleta, Á. de Pablo Cárdenas, (unknown), Marı́a Isabel Cadavid, Marı́a Isabel Loza, Hamish Ryder, Bernat Vidal	20
10	Phosphodiesterase 7A1 is expressed in human CD4+ naïve T cells at higher levels than in CD4+ memory cells and is not required during their CD3/CD28-dependent activation 2006 ·Cellular Immunology ·Arsenio Nueda, (unknown), Teresa Domènech, Núria Godessart, Á. de Pablo Cárdenas, Luis F. Santamaria‐Babí, Jörge Beleta	6
11	Dynamic Localization/Association of Protein Kinase CK2 Subunits in Living Cells 2002 ·Annals of the New York Academy of Sciences ·Véronique Martel, Odile Filhol, Arsenio Nueda, Claude Cochet	34
12	c-Myc inhibits CD11a and CD11c leukocyte integrin promoters 2000 ·European Journal of Immunology ·Cristina López-Rodrı́guez, M. Dolores Delgado, Amaya Puig‐Kröger, Arsenio Nueda, Eduardo Muñóz, Javier León, Carmelo Bernabéu, Ángel L. Corbí	9
13	Polyomavirus Enhancer-binding Protein 2/Core Binding Factor/Acute Myeloid Leukemia Factors Contribute to the Cell Type-specific Activity of the CD11a Integrin Gene Promoter 2000 ·Journal of Biological Chemistry ·Amaya Puig‐Kröger, Cristina López-Rodrı́guez, Miguel Relloso, Tilman Sánchez-Elsner, Arsenio Nueda, Eduardo Muñóz, Carmelo Bernabéu, Ángel L. Corbí	25
14	Analysis of the phosphorylation of human heat shock transcription factor-1 by MAP kinase family members 1997 ·Journal of Cellular Biochemistry ·Juyong Brian Kim, Arsenio Nueda, Yonghong Meng, William S. Dynan, Nahid F. Mivechi	74
15	Heat Shock Transcription Factor 1 Binds Selectively in Vitro to Ku Protein and the Catalytic Subunit of the DNA-dependent Protein Kinase 1997 ·Journal of Biological Chemistry ·(unknown), Arsenio Nueda, (unknown), William S. Dynan	44
16	Hematopoietic Cell-Type-Dependent Regulation of Leukocyte Integrin Functional Activity: CD11b and CD11c Expression Inhibits LFA-1-Dependent Aggregation of Differentiated U937 Cells 1995 ·Cellular Immunology ·Arsenio Nueda, Cristina López-Rodrı́guez, Miguel A. Rubio, Sol Sotillos, Antonio Postigo, Miguel Á. del Pozo, Miguel A. Vega, Ángel L. Corbí	16
17	CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. 1994 ·The Journal of Immunology ·Jean‐Pierre Aubry, Sibylle Pochon, J F Gauchat, Arsenio Nueda, V. Michael Holers, Pierre Graber, Carla J. Siegfried, J Y Bonnefoy	84
18	Characterization of two new CD18 alleles causing severe leukocyte adhesion deficiency 1993 ·European Journal of Immunology ·Cristina López-Rodrı́guez, Arsenio Nueda, (unknown), Alain Fischer, Timothy A. Springer, Ángel L. Corbí	20
19	Characterization of the CD11a (alpha L, LFA-1 alpha) integrin gene promoter. 1993 ·Journal of Biological Chemistry ·Arsenio Nueda, Manuel López‐Cabrera, Alicia Vara, Ángel L. Corbí	35
20	A single mRNA encodes the α¹⁵⁰ and α^80/70 forms of the α subunit of VLA4 1992 ·European Journal of Immunology ·Miguel Rubio, Arsenio Nueda, Alicia Vara, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact